Regulatory
J&J’s Imaavy Becomes the First Approved Treatment for a Rare Autoimmune Anemia
Nipocalimab wins FDA approval for warm autoimmune hemolytic anemia — a disease in which the immune system destroys the body’s own red blood cells — giving patients their first dedicated therapy.